Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2022 Publisher: REX Medical Ltd, Unit 18/273 Neilson Street, Onehunga, Auckland 1061, PO Box 18-119, Glen Innes 1743, AUCKLAND Ph (09) 574 6060 Fax (09) 574 6070
Melorex.
Pharmaceutical Form |
---|
Melorex 7.5 mg tablets are pale yellow coloured, circular flat beveled uncoated tablets. Melorex 15 mg tablets are pale yellow coloured, circular flat beveled uncoated tablets with central breakline on one side and plain on the other. |
Meloxicam tablets 7.5 mg, 15 mg.
Excipient(s) with known effect:
Each 7.5 mg tablet contains 43 mg of lactose monohydrate.
Each 15 mg tablet contains 86 mg of lactose monohydrate.
For full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Meloxicam |
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam family, with anti-inflammatory, analgesic and antipyretic properties. The anti-inflammatory activity of meloxicam has been proven in classical models of inflammation. As with other NSAID, its precise mechanism of action remains unknown. However, there is at least one common mode of action shared by all NSAID (including meloxicam): inhibition of the biosynthesis of prostaglandins, known inflammation mediators. |
List of Excipients |
---|
Colloidal anhydrous silica |
Al/PVC/PVdC blister packs:
7.5mg = 30 tablets
15mg = 30 tablets
REX Medical Ltd, Unit 18/273 Neilson Street, Onehunga, Auckland 1061, PO Box 18-119, Glen Innes 1743, AUCKLAND
Ph (09) 574 6060
Fax (09) 574 6070
Date of first approval: 15 November 2007
Drug | Countries | |
---|---|---|
MELOREX | Ecuador, New Zealand |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.